目前同步放化疗已成为局部晚期鼻咽癌的标准治疗。
Concomitant radiochemotherapy has become the standard treatment of local advanced nasopharyngeal carcinoma now.
医生发现，与只接受同步放化疗的患者相比，接受诱导治疗和同步放化疗的患者，其总生存率升高较小，但很显著。
Doctors found a small but significant increase in overall survival in the patients who received the induction therapy with chemoradiation versus the chemoradiation-only group.
结论：同步放化疗治疗局部晚期非小细胞肺癌具有较好的疗效，不良反应可耐受，治疗失败原因主要为远处转移。
Conclusions: Concurrent radiochemotherapy is a feasible, well tolerated and active scheme in the treatment of locally advanced NSCLC. The major pattern of failure is distant metastasis.
应用推荐